<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01512147</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00007472</org_study_id>
    <nct_id>NCT01512147</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients</brief_title>
  <official_title>Measuring the Effects of Dexmedetomidine on Somatosensory Evoked and Muscular Evoked Potential During Neurosurgery in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to know if using the study drug dexmedetomidine will improve nerve
      wave readings during neurosurgery. These readings are done many times during surgery while
      the patient is asleep. The readings look at how nerves are working and let the operating team
      know if nerves are hurt during surgery. If the readings tell that nerves are not working
      correctly, the surgeons can help while changing the way of operating.

      The study drug will be used in addition to the general anesthesia that a patient is given.
      The nerve readings that the investigators get while using the study drug will be compared
      with nerve readings that the investigators get while not using the study drug.

      The study hypothesis is that dexmedetomidine does not change nerve readings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Somatosensory evoked potential (SSEP) and motor evoked potential (MEP) have become an
      integral component in intraoperative care of patients and have resulted in a high degree of
      sensitivity in predicting neurologic outcomes. According to Padberg, Nuwer and Ecker ,SSEP
      and MEP monitoring allows surgical interventions to occur early and thus decreases the
      incidence of postoperative neurologic deficits.

      These measurements are done during surgery under general anesthesia and it is known that
      anesthetic agents have a dose-dependent adverse effect on the ability to record evoked
      potential responses. All anesthesia agents seem to interfere with the measurements especially
      in higher doses.

      In 1999, dexmedetomidine, a highly specific and selective alpha-2-adrenergic agonist with
      sedative, anxiolytic and analgesic effects, got FDA approved for adult patients for sedation.
      Since then, it has also been widely used off-label in various settings; it is described as a
      successful adjunct for surgical procedures in adolescents and adult populations where SSEP/
      MEP monitoring is beneficial. Several small and retrospective studies have shown that
      dexmedetomidine does not appear to interfere with neurophysiological monitoring when used in
      FDA approved doses.

      In pediatric patients, dexmedetomidine is also used off-label and has been shown to be
      beneficial. In fact, at Doernbecher Childen's Hospital, the use of dexmedetomidine has become
      a standard in pediatric procedures involving SSEP and MEP measurements. To the best of our
      knowledge, prospective studies in pediatric patients with SSEP monitoring while using
      dexmedetomidine have not been completed.

      If dexmedetomidine does not interfere the SSEP/MEP reading, it might be an advantageous
      adjunct to use in these settings. Propofol has a small risk of a serious side effect called
      propofol infusion syndrome. Propofol infusion syndrome is potentially life threatening, with
      the development of a profound lactate acidosis. It is seen when large doses of propofol
      (usually from a prolonged infusion) are given in the pediatric population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant improvement of MEP and SSEP readings during neurosurgery for pediatric patients while using dexmedetomidine as an adjunct to general anesthesia and therefore improvement in clinical decision making.</measure>
    <time_frame>30 - 60 minutes of SSEP and MEP measurements intraoperatively</time_frame>
    <description>Changes in latency and amplitude of SSEP and changes in amplitude and morphology of MEP while using different anesthetic combinations including isoflurane, propofol and dexmedetomidine.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Tethered Spinal Cord</condition>
  <condition>Brain Tumor</condition>
  <condition>Cranio Cervical Compression</condition>
  <arm_group>
    <arm_group_label>Isoflurane, Propofol, Dexmedetomidine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Our trial will examine the changes in latency and amplitude of SSEP and changes in amplitude and morphology of MEP while using different anesthetic combinations including isoflurane, proposal and dexmedetomidine. Monitoring teams will document any changes throughout the surgery and communicate with the team about those changes. The design of the study will be a prospective AB design.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Isoflurane, Propofol, Dexmedetomidine</intervention_name>
    <description>We will include following general anesthesia techniques:
Fentanyl 1 - 2 mcg/kg/hr, Propofol 150 - 250 mcg/kg/min, Isoflurane 0.6% expiratory With this general anesthesia technique we will do our first SSEP/MEP measurements after 30 minutes.
After 30 minutes we will stop isoflurane and will wash out the inhalational anesthetic with high flow air/oxygen and provide:
Fentanyl 1 - 2 mcg/kg/hr, Propofol 150 - 250mcg/kg/min. This technique will be held for 30 minutes. SSEP/ MEP measurements will be done after 30 minutes.
After the measurements dexmedetomidine will be added with a loading dose of 0.5 mcg/kg over 10 minutes and continuous infusion of 0.5 mcg/kg/hr for 30 minutes.
Fentanyl 1 -2 mcg/kg/hr, Propofol 100 - 250mcg/kg/min, Dexmedetomidine 0.5 mcg/kg/hr.</description>
    <arm_group_label>Isoflurane, Propofol, Dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients between 2 and 12 years old

          -  Undergoing neurosurgery and

          -  Requiring SSEP/ MEP measurements

        Exclusion Criteria:

          -  Patients younger than 2 and older than 12 years

          -  Patients with known bradyarrhythmias

          -  Patients with severe liver disease

          -  Conditions that may alter reading, e.g. neuromuscular diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heike Gries, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ohsu - Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Padberg AM, Wilson-Holden TJ, Lenke LG, Bridwell KH. Somatosensory- and motor-evoked potential monitoring without a wake-up test during idiopathic scoliosis surgery. An accepted standard of care. Spine (Phila Pa 1976). 1998 Jun 15;23(12):1392-400.</citation>
    <PMID>9654631</PMID>
  </reference>
  <reference>
    <citation>Ecker ML, Dormans JP, Schwartz DM, Drummond DS, Bulman WA. Efficacy of spinal cord monitoring in scoliosis surgery in patients with cerebral palsy. J Spinal Disord. 1996 Apr;9(2):159-64.</citation>
    <PMID>8793785</PMID>
  </reference>
  <reference>
    <citation>Nuwer MR, Dawson EG, Carlson LG, Kanim LE, Sherman JE. Somatosensory evoked potential spinal cord monitoring reduces neurologic deficits after scoliosis surgery: results of a large multicenter survey. Electroencephalogr Clin Neurophysiol. 1995 Jan;96(1):6-11.</citation>
    <PMID>7530190</PMID>
  </reference>
  <reference>
    <citation>Thuet ED, Padberg AM, Raynor BL, Bridwell KH, Riew KD, Taylor BA, Lenke LG. Increased risk of postoperative neurologic deficit for spinal surgery patients with unobtainable intraoperative evoked potential data. Spine (Phila Pa 1976). 2005 Sep 15;30(18):2094-103.</citation>
    <PMID>16166902</PMID>
  </reference>
  <reference>
    <citation>Banoub M, Tetzlaff JE, Schubert A. Pharmacologic and physiologic influences affecting sensory evoked potentials: implications for perioperative monitoring. Anesthesiology. 2003 Sep;99(3):716-37. Review.</citation>
    <PMID>12960558</PMID>
  </reference>
  <reference>
    <citation>Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000 Feb;59(2):263-8; discussion 269-70.</citation>
    <PMID>10730549</PMID>
  </reference>
  <reference>
    <citation>Tobias JD, Goble TJ, Bates G, Anderson JT, Hoernschemeyer DG. Effects of dexmedetomidine on intraoperative motor and somatosensory evoked potential monitoring during spinal surgery in adolescents. Paediatr Anaesth. 2008 Nov;18(11):1082-8. doi: 10.1111/j.1460-9592.2008.02733.x.</citation>
    <PMID>18717802</PMID>
  </reference>
  <reference>
    <citation>Bala E, Sessler DI, Nair DR, McLain R, Dalton JE, Farag E. Motor and somatosensory evoked potentials are well maintained in patients given dexmedetomidine during spine surgery. Anesthesiology. 2008 Sep;109(3):417-25. doi: 10.1097/ALN.0b013e318182a467.</citation>
    <PMID>18719439</PMID>
  </reference>
  <reference>
    <citation>Anschel DJ, Aherne A, Soto RG, Carrion W, Hoegerl C, Nori P, Seidman PA. Successful intraoperative spinal cord monitoring during scoliosis surgery using a total intravenous anesthetic regimen including dexmedetomidine. J Clin Neurophysiol. 2008 Feb;25(1):56-61. doi: 10.1097/WNP.0b013e318163cca6.</citation>
    <PMID>18303561</PMID>
  </reference>
  <reference>
    <citation>Mahmoud M, Sadhasivam S, Salisbury S, Nick TG, Schnell B, Sestokas AK, Wiggins C, Samuels P, Kabalin T, McAuliffe J. Susceptibility of transcranial electric motor-evoked potentials to varying targeted blood levels of dexmedetomidine during spine surgery. Anesthesiology. 2010 Jun;112(6):1364-73. doi: 10.1097/ALN.0b013e3181d74f55.</citation>
    <PMID>20460997</PMID>
  </reference>
  <reference>
    <citation>Bloom M, Beric A, Bekker A. Dexmedetomidine infusion and somatosensory evoked potentials. J Neurosurg Anesthesiol. 2001 Oct;13(4):320-2.</citation>
    <PMID>11733664</PMID>
  </reference>
  <reference>
    <citation>MÃ¸ller AR. Intraoperative neurophysiologic monitoring. Am J Otol. 1995 Jan;16(1):115-7.</citation>
    <PMID>8579167</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2011</study_first_submitted>
  <study_first_submitted_qc>January 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2012</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Heike Gries, MD, PhD</investigator_full_name>
    <investigator_title>Assistant Professor, Pediatric Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>SSEP measurements</keyword>
  <keyword>MEP measurements</keyword>
  <keyword>Pediatric Patients</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>General Anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

